GlassScriptPhysician profile
Bruce A Cutter
NPI 1356337349
$1,221.41
in general payments reported to CMS, 2019-2025
24 companies · $34.62 in 2025
The $34.62 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $247 · 2021: $40.35 · 2022: $65.83 · 2024: $19.59 · 2025: $34.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $209.47 | 2019-2022 | |
| Pfizer INC. | $138.94 | 2019-2020 | |
| Amgen INC. | $105.62 | 2019-2020 | |
| Genentech USA, INC. | $81.76 | 2019-2021 | |
| Gilead Sciences, INC. | $62.93 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $56.22 | 2019 | |
| Astellas Pharma US INC | $55.08 | 2019 | |
| Lilly USA, LLC | $51.69 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $51.44 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.61 | 2019 | |
| Janssen Biotech, INC. | $38.07 | 2020 | |
| Eisai INC. | $37.09 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.64 | 2019-2020 | |
| Seagen INC. | $35.34 | 2019-2022 | |
| Abbvie INC. | $34.62 | 2025 | Epkinly, Imbruvica |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $33.04 | 2019-2020 | |
| Genzyme Corporation | $27.13 | 2019 | |
| Coherus Oncology, INC. | $21.95 | 2020 | |
| Amag Pharmaceuticals, INC. | $19.17 | 2020 | |
| Exelixis INC. | $17.33 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $16.45 | 2019 | |
| Emd Serono, INC. | $15.00 | 2019 | |
| Array Biopharma INC | $14.77 | 2019 | |
| Dova Pharmaceuticals | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Cutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.